NCT04000880Completed
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
This research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors of breast, prostate, colorectal, endometrial, renal, thyroid, and ovarian cancers, as well as multiple myeloma and non-Hodgkin Lymphoma. Overarching outcomes also include physical function and performance, muscle mass, quality of life, and health utilities.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 603 (actual)
- First submitted
- 21 Jun 2019
- Start date
- 4 Mar 2020
- Primary completion date
- 1 Apr 2025
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Prostate cancer, Thyroid cancer, Kidney cancer, Endometrial cancer, Colorectal cancer, Multiple myeloma, Ovarian cancer
- NCT number
- NCT04000880
What you commit to
- Study type: Interventional
- Participants enrolled: 603
- From 4 Mar 2020 to the primary completion date, 1 Apr 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of progressive cancer of the eligible types.
- Recurrence of the eligible cancer types (exceptions are biochemical recurrence of prostate cancer).
- Pre-existing medical conditions that preclude adherence to an unsupervised weight loss intervention (e.g., pregnancy, severe orthopedic conditions, impending hip or knee replacement (within 6 months), end-stage renal disease, paralysis, dementia, blindness, unstable angina, untreated stage 3 hypertension, or recent history of heart attack, congestive heart failure or pulmonary conditions that required oxygen or hospitalization within 6 months).
- Second primary cancers, with the exception of non-melanoma skin cancer, or if the initial and second cancers are both deemed eligible cancers.
Other
- Participation in another diet and exercise program.
- A physician has provided instruction to limit current physical activity.
- Reside in a skilled nursing or assisted living facility.
Who the study is looking for
- Age 50 years or older
- Resident of the continental United States
- Diagnosed with multiple myeloma, non-Hodgkin lymphoma, or localized kidney or ovarian cancer; or \[localized (includes in situ) through regional\] breast, colorectum, endometrium, thyroid, or prostate cancer.
- Completed primary treatment (surgery, radiation or chemotherapy). Active surveillance among men with prostate cancer or women with ductal carcinoma in situ is acceptable.
- Completion of the 8th grade of school. Able to read and write English.
- Normal blood pressure or those with high blood pressure for whom physician permission was granted.
- Community dwelling.
- Reside in an area that receives wireless coverage.
- Have an active email address or be willing to have one created for the study.
- Current body mass index of greater than or equal to 25 kg/m2, but less than 50 kg/m2.
- Current physical activity level is less than 150 minutes of moderate-to-vigorous exercise per week.
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
| University of Tennessee Health Science Center Coordinator of this site? Confirm its status | Memphis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.